Sysmex Co. (OTCMKTS:SSMXY - Get Free Report) was the target of a large growth in short interest in April. As of April 15th, there was short interest totalling 73,300 shares, a growth of 633.0% from the March 31st total of 10,000 shares. Approximately 0.0% of the shares of the company are short sold. Based on an average trading volume of 192,200 shares, the short-interest ratio is presently 0.4 days.
Sysmex Stock Performance
OTCMKTS:SSMXY traded down $0.34 during mid-day trading on Wednesday, hitting $18.46. 38,897 shares of the company's stock traded hands, compared to its average volume of 68,642. The firm has a market capitalization of $11.62 billion, a price-to-earnings ratio of 36.87 and a beta of 1.08. Sysmex has a 12 month low of $14.38 and a 12 month high of $22.00. The firm has a 50 day moving average of $18.59 and a two-hundred day moving average of $18.92. The company has a current ratio of 3.19, a quick ratio of 2.42 and a debt-to-equity ratio of 0.11.
Sysmex (OTCMKTS:SSMXY - Get Free Report) last announced its quarterly earnings results on Wednesday, February 12th. The company reported $0.17 earnings per share for the quarter. On average, equities analysts forecast that Sysmex will post 0.57 earnings per share for the current fiscal year.
About Sysmex
(
Get Free Report)
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.
Further Reading
Before you consider Sysmex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sysmex wasn't on the list.
While Sysmex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
